BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock
1.56 EUR
0 (-0.13%)
Taking everything into account, ALTUV scores 4 out of 10 in our fundamental rating. ALTUV was compared to 109 industry peers in the Machinery industry. Both the profitability and the financial health of ALTUV get a neutral evaluation. Nothing too spectacular is happening here. ALTUV is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ALTUV was profitable.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in each of the past 5 years.
ALTUV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of ALTUV (1.36%) is worse than 65.14% of its industry peers.
ALTUV has a worse Return On Equity (2.41%) than 66.97% of its industry peers.
ALTUV has a worse Return On Invested Capital (2.84%) than 70.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.88%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
1.3 Margins
The Profit Margin of ALTUV (2.64%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALTUV has declined.
ALTUV has a Operating Margin of 5.93%. This is comparable to the rest of the industry: ALTUV outperforms 48.62% of its industry peers.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
ALTUV has a Gross Margin (38.14%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTUV is destroying value.
Compared to 1 year ago, ALTUV has less shares outstanding
Compared to 5 years ago, ALTUV has more shares outstanding
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
2.2 Solvency
ALTUV has an Altman-Z score of 1.44. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.44, ALTUV is doing worse than 65.14% of the companies in the same industry.
The Debt to FCF ratio of ALTUV is 7.69, which is on the high side as it means it would take ALTUV, 7.69 years of fcf income to pay off all of its debts.
ALTUV has a Debt to FCF ratio (7.69) which is in line with its industry peers.
A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
ALTUV has a Debt to Equity ratio (0.39) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Altman-Z | 1.44 |
ROIC/WACC0.39
WACC7.19%
2.3 Liquidity
ALTUV has a Current Ratio of 2.05. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.05, ALTUV is in the better half of the industry, outperforming 77.98% of the companies in the same industry.
A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
The Quick ratio of ALTUV (1.31) is better than 72.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
ALTUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.24%, which is quite impressive.
The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -7.99% in the last year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ALTUV is valuated rather expensively with a Price/Earnings ratio of 22.29.
60.55% of the companies in the same industry are more expensive than ALTUV, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ALTUV to the average of the S&P500 Index (26.29), we can say ALTUV is valued inline with the index average.
With a Price/Forward Earnings ratio of 15.15, ALTUV is valued correctly.
ALTUV's Price/Forward Earnings ratio is in line with the industry average.
ALTUV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.29 | ||
| Fwd PE | 15.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALTUV is valued a bit cheaper than 63.30% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaply inside the industry as 80.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.04 | ||
| EV/EBITDA | 9.02 |
4.3 Compensation for Growth
ALTUV's earnings are expected to grow with 14.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.50%, ALTUV has a reasonable but not impressive dividend return.
ALTUV's Dividend Yield is a higher than the industry average which is at 2.37.
Compared to an average S&P500 Dividend Yield of 2.31, ALTUV has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPA:ALTUV (12/9/2025, 7:00:00 PM)
1.56
0 (-0.13%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.07M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (96.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.29 | ||
| Fwd PE | 15.15 | ||
| P/S | 0.58 | ||
| P/FCF | 8.04 | ||
| P/OCF | 4.63 | ||
| P/B | 0.53 | ||
| P/tB | 4.31 | ||
| EV/EBITDA | 9.02 |
EPS(TTM)0.07
EY4.49%
EPS(NY)0.1
Fwd EY6.6%
FCF(TTM)0.19
FCFY12.44%
OCF(TTM)0.34
OCFY21.6%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROCE | 3.87% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.55% | ||
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.26% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Debt/EBITDA | 3.38 | ||
| Cap/Depr | 79.6% | ||
| Cap/Sales | 5.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.7% | ||
| Profit Quality | 275.52% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.44 |
F-Score7
WACC7.19%
ROIC/WACC0.39
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.